Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wakioka

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|August 10, 2001
Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activationA Sasaki, T Taketomi, T Wakioka, et al.
Leukemia|June 22, 1999
APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-CblT Wakioka, A Sasaki, K Mitsui, et al.
Oncogene|November 12, 1998
CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cellsR Suzuki, H Sakamoto, H Yasukawa, et al.
Nature|August 9, 2001
Spred is a Sprouty-related suppressor of Ras signallingT Wakioka, A Sasaki, R Kato, et al.
Oncogene|February 16, 1999
APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesisM Yokouchi, T Wakioka, H Sakamoto, et al.
Optics Letters|November 3, 2010
One-dimensional Wolter optics with a sub-50 nm spatial resolutionS Matsuyama, T Wakioka, N Kidani, et al.
The EMBO Journal|March 4, 1999
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loopH Yasukawa, H Misawa, H Sakamoto, et al.
The Journal of Clinical Investigation|December 19, 2001
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritisT Shouda, T Yoshida, T Hanada, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
Cloning and characterization of novel CIS family genesM Masuhara, H Sakamoto, A Matsumoto, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|August 10, 2001
Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activationA Sasaki, T Taketomi, T Wakioka, et al.
Leukemia|June 22, 1999
APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-CblT Wakioka, A Sasaki, K Mitsui, et al.
Oncogene|November 12, 1998
CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cellsR Suzuki, H Sakamoto, H Yasukawa, et al.
Nature|August 9, 2001
Spred is a Sprouty-related suppressor of Ras signallingT Wakioka, A Sasaki, R Kato, et al.
Oncogene|February 16, 1999
APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesisM Yokouchi, T Wakioka, H Sakamoto, et al.
Optics Letters|November 3, 2010
One-dimensional Wolter optics with a sub-50 nm spatial resolutionS Matsuyama, T Wakioka, N Kidani, et al.
The EMBO Journal|March 4, 1999
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loopH Yasukawa, H Misawa, H Sakamoto, et al.
The Journal of Clinical Investigation|December 19, 2001
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritisT Shouda, T Yoshida, T Hanada, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
Cloning and characterization of novel CIS family genesM Masuhara, H Sakamoto, A Matsumoto, et al.
Pageof 1